Open AccessThe REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema
Author(s) -
Shiyue Li,
Guangfa Wang,
Changhui Wang,
Xinglin Gao,
Faguang Jin,
Huaping Yang,
Baohui Han,
Rui Zhou,
Chengshui Chen,
Liangan Chen,
Chunxue Bai,
Huahao Shen,
Felix J.F. Herth,
Nanshan Zhong
Publication year - 2018
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000494327
Subject(s) - medicine , randomized controlled trial , physical therapy , intensive care medicine , surgery
Chronic obstructive pulmonary disease (COPD) has become a leading cause of morbidity and mortality in China, with tobacco smoke, air pollution, and occupational biohazards being the major risk factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom